If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
550.00    -6.00 (-1.09%)
Bid:
540.00
Ask:
560.00
Spread: 20.00 (3.704%)
Market Cap: £89.07m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Director/PDMR Shareholding

27 Sep 2011 15:25

KIOTECH INTERNATIONAL PLC ("Kiotech" or "the Company")

Issue of Shares under Joint Share Ownership Scheme

The Company announces that the Company has, on 27 September 2011, issued and allotted a total of 587,742 new ordinary shares of 23p each in the Company ("Ordinary Shares"), representing 3.15 per cent of the enlarged issued share capital of the Company, at a subscription price of 85.5p per ordinary share, this being the closing price of a share in the Company on 26 September 2011, pursuant to The Kiotech International plc Employees' Joint Share Ownership Plan ("the Plan").

The shares have been respectively issued into the joint beneficial ownership of (i) each of the three participating executive Directors named below and (ii) the trustee of The Kiotech International plc Employees' Share Trust ("the Trust") upon and subject to the terms of joint ownership agreements ("JOAs") respectively entered into between the Director concerned, the Company and RBC cees Trustee Limited as trustee of the Trust ("the Trustee"). The aggregate subscription monies for the jointly owned shares, totalling £502,519, have been paid by the Trustee out of monies advanced on loan to the Trustee by the Company.

Name of Director Jointly Owned Shares Awarded Total Subscription Monies (at 85.5 pence per Share) Subscription monies paid by Director
Richard Edwards 42,742 36,544 nil
David Bullen 370,000 316,350 nil
Karen Prior 175,000 149,625 nil

The participating directors' interests in the Jointly Owned Shares vest after three years.

Application has been made for admission to trading on AIM of the new Ordinary Shares, which is expected to be effective from tomorrow, 28 September 2011.

Note:

The Plan was established and approved by resolution of the non-executive Directors on 26 September 2011 and provides for the acquisition by employees, including executive Directors, of beneficial interests as joint owners (with the Trust) of Ordinary Shares in the Company upon the terms of a JOA. The terms of the JOA provide, inter alia, that if jointly owned shares become vested and are sold, the proceeds of sale will be divided between the joint owners so that the participating Director receives an amount equal to any growth in the market value of the Jointly Owned Shares since the time of issue of these shares, less a "carrying cost" (equivalent to simple interest at 4.5 per cent per annum on the initial market value of the shares), and the Trust receives the initial market value of the jointly owned shares plus the carrying cost.

A participating Director's interest in the Jointly Owned Shares will vest after 3 years unless he or she leaves the Company within that period for any reason other than death, injury, disability or ill-health, retirement or in consequence of the sale of a business or subsidiary.

Disclosure and Transparency Rules

In accordance with the FSA's Disclosure and Transparency Rules, the Company's issued share capital following the issue of the new Ordinary Shares will comprise 18,887,694 ordinary shares of 23p with voting rights. The Company holds 235,000 shares in Treasury. The total number of ordinary shares in issue (excluding shares held as treasury shares) is 18,652,694 and may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Enquiries:

Kiotech International plcRichard Edwards, Executive Vice-Chairman +44 (0)777 641 7129Karen Prior, Group Finance Director +44 (0)771 863 2303

FinnCapMatthew Robinson / Henrik Persson - Corporate FinanceStephen Norcross - Corporate Broking+44 (0)20 7220 0500

Copyright Business Wire 2011

Date   Source Headline
16th Dec 20247:00 amRNSExercise of Options and Director/PDMR Shareholding
16th Dec 20247:00 amRNSLaunch of SAYE Scheme
29th Nov 20247:00 amRNSTotal Voting Rights
30th Sep 20247:00 amRNSAcquisition of Bio-Vet Inc.
13th Sep 20247:00 amRNSNotice of Investor Presentation
11th Sep 20247:00 amRNSInterim results
14th Aug 202411:22 amRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNSBlock listing Interim Review
25th Jun 20242:34 pmRNSResult of AGM
25th Jun 20247:00 amRNSAGM Statement
12th Jun 20244:11 pmRNSHolding(s) in Company
24th May 202410:04 amRNSPosting of Annual Report and Notice of AGM
21st Mar 202411:37 amRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSAward of Options and Director/PDMR Shareholding
24th Jan 20247:00 amRNSFull year trading statement
17th Jan 20247:00 amRNSBlock listing Interim Review
5th Oct 20239:23 amRNSDirector Disclosure
13th Sep 20237:00 amRNSHalf-year Report
25th Aug 20235:10 pmRNSBlock listing Interim Review
1st Aug 20237:00 amRNSDirectorate Change
10th Jul 20232:14 pmRNSHolding(s) in Company
7th Jul 20232:34 pmRNSHolding(s) in Company
29th Jun 20233:57 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
23rd Jun 20237:00 amRNSResult of Tender Offer
19th Jun 20232:48 pmRNSGM Statement
15th Jun 20237:00 amRNSShareholder Tour
7th Jun 20234:09 pmRNSReplacement - Tender Offer
6th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20237:00 amRNSTender Offer
23rd May 20237:00 amRNSChange of Adviser
19th May 20234:40 pmRNSDirector Disclosures
19th May 20233:35 pmRNSTotal Voting Rights
5th May 20237:00 amRNSDirectorate Change
21st Apr 20237:00 amRNSAnpario receives King’s Award for Enterprise
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20231:13 pmRNSHolding(s) in Company
28th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSFinal Results
3rd Feb 20237:00 amRNSDirector/PDMR Shareholding
24th Jan 202312:56 pmRNSBlock listing Interim Review
9th Jan 20237:00 amRNSFull Year Trading Statement
16th Dec 20227:00 amRNSAnpario receives ISO 14001 Certification
4th Nov 202212:52 pmRNSTotal Voting Rights
19th Oct 20227:00 amRNSDirector/PDMR Shareholding - Replacement
18th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSESG Initiatives
3rd Oct 20222:32 pmRNSDirector/PDMR Shareholding
14th Sep 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.